دورية أكاديمية
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
| العنوان: | Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. |
|---|---|
| المؤلفون: | Aure MR; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Vitelli V; Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway., Jernström S; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Kumar S; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Krohn M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Due EU; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Haukaas TH; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Leivonen SK; Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland., Vollan HK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Lüders T; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Rødland E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Vaske CJ; Five3 Genomics, LLC, Santa Cruz, CA, 95060, USA., Zhao W; Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Møller EK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Nord S; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Giskeødegård GF; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Bathen TF; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Caldas C; Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Tramm T; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Bukholm IR; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Surgery, Akershus University Hospital, Lørenskog, Norway., Naume B; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Schlichting E; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway., Sauer T; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Mills GB; Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kåresen R; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Lingjærde OC; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway.; Department of Computer Science, University of Oslo, Oslo, Norway., Frigessi A; Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway.; Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Sahlberg KK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. kristine.sahlberg@vestreviken.no.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. kristine.sahlberg@vestreviken.no.; Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. kristine.sahlberg@vestreviken.no. |
| مؤلفون مشاركون: | OSBREAC |
| المصدر: | Breast cancer research : BCR [Breast Cancer Res] 2017 Mar 29; Vol. 19 (1), pp. 44. Date of Electronic Publication: 2017 Mar 29. |
| نوع المنشور: | Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London, UK : BioMed Central Ltd Original Publication: London, UK : Current Science, c1999- |
| مواضيع طبية MeSH: | Biomarkers, Tumor* , Cluster Analysis*, Breast Neoplasms/*genetics , Breast Neoplasms/*metabolism, Breast Neoplasms/epidemiology ; Breast Neoplasms/mortality ; DNA Copy Number Variations ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Metabolic Networks and Pathways ; Metabolomics/methods ; MicroRNAs/genetics ; Norway/epidemiology ; Prognosis ; RNA, Messenger/genetics |
| مستخلص: | Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this study we integrate classifications extracted from five different molecular levels in order to identify integrated subtypes. Methods: Tumor tissue from 425 patients with primary breast cancer from the Oslo2 study was cut and blended, and divided into fractions for DNA, RNA and protein isolation and metabolomics, allowing the acquisition of representative and comparable molecular data. Patients were stratified into groups based on their tumor characteristics from five different molecular levels, using various clustering methods. Finally, all previously identified and newly determined subgroups were combined in a multilevel classification using a "cluster-of-clusters" approach with consensus clustering. Results: Based on DNA copy number data, tumors were categorized into three groups according to the complex arm aberration index. mRNA expression profiles divided tumors into five molecular subgroups according to PAM50 subtyping, and clustering based on microRNA expression revealed four subgroups. Reverse-phase protein array data divided tumors into five subgroups. Hierarchical clustering of tumor metabolic profiles revealed three clusters. Combining DNA copy number and mRNA expression classified tumors into seven clusters based on pathway activity levels, and tumors were classified into ten subtypes using integrative clustering. The final consensus clustering that incorporated all aforementioned subtypes revealed six major groups. Five corresponded well with the mRNA subtypes, while a sixth group resulted from a split of the luminal A subtype; these tumors belonged to distinct microRNA clusters. Gain-of-function studies using MCF-7 cells showed that microRNAs differentially expressed between the luminal A clusters were important for cancer cell survival. These microRNAs were used to validate the split in luminal A tumors in four independent breast cancer cohorts. In two cohorts the microRNAs divided tumors into subgroups with significantly different outcomes, and in another a trend was observed. Conclusions: The six integrated subtypes identified confirm the heterogeneity of breast cancer and show that finer subdivisions of subtypes are evident. Increasing knowledge of the heterogeneity of the luminal A subtype may add pivotal information to guide therapeutic choices, evidently bringing us closer to improved treatment for this largest subgroup of breast cancer. |
| References: | NMR Biomed. 2006 Feb;19(1):30-40. (PMID: 16229059) Cell. 2014 Aug 14;158(4):929-944. (PMID: 25109877) Sci Transl Med. 2010 Jun 30;2(38):38ra47. (PMID: 20592421) Mol Oncol. 2015 Jan;9(1):115-27. (PMID: 25169931) Bioinformatics. 2004 Nov 22;20(17):3246-8. (PMID: 15180930) Genome Biol. 2013 Nov 20;14(11):R126. (PMID: 24257477) Nucleic Acids Res. 2009 Jan;37(Database issue):D674-9. (PMID: 18832364) Cancer Metab. 2016 Jun 27;4:12. (PMID: 27350877) Nat Rev Cancer. 2011 Nov 17;11(12):835-48. (PMID: 22089420) Bioinformatics. 2007 Aug 1;23(15):1986-94. (PMID: 17599930) Curr Opin Cell Biol. 2008 Apr;20(2):164-70. (PMID: 18358709) Bioinformatics. 2004 Jun 12;20(9):1453-4. (PMID: 14871861) Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7. (PMID: 24243840) Nat Rev Cancer. 2004 Nov;4(11):891-9. (PMID: 15516961) Bioinformatics. 2010 Jun 15;26(12):1572-3. (PMID: 20427518) Bioinformatics. 2010 Jun 15;26(12):i237-45. (PMID: 20529912) BMC Genomics. 2012 Nov 04;13:591. (PMID: 23442169) Nat Commun. 2016 May 10;7:11479. (PMID: 27161491) Genome Med. 2015 Feb 02;7(1):21. (PMID: 25873999) BMC Res Notes. 2015 Apr 22;8:164. (PMID: 25899823) Nature. 2012 Oct 4;490(7418):61-70. (PMID: 23000897) Nature. 2000 Aug 17;406(6797):747-52. (PMID: 10963602) Bioinformatics. 2009 Sep 1;25(17):2149-56. (PMID: 19535535) Nat Rev Cancer. 2014 May;14(5):299-313. (PMID: 24759209) Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72. (PMID: 12011421) Bioinformatics. 2008 Mar 15;24(6):759-67. (PMID: 18204055) J Clin Oncol. 2009 Mar 10;27(8):1160-7. (PMID: 19204204) Cancer Res. 2008 Aug 1;68(15):6084-91. (PMID: 18676830) Bioinformatics. 2009 Nov 15;25(22):2906-12. (PMID: 19759197) Mol Oncol. 2013 Jun;7(3):392-401. (PMID: 23253899) Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1848-55. (PMID: 22989461) Genome Res. 2007 Nov;17(11):1665-74. (PMID: 17921354) Int J Oncol. 2010 Jul;37(1):61-9. (PMID: 20514397) PLoS One. 2011 Feb 22;6(2):e16915. (PMID: 21364938) Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2802-7. (PMID: 21908711) Nucleic Acids Res. 2008 Nov;36(19):e126. (PMID: 18784189) Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74. (PMID: 11553815) Mol Cancer Ther. 2006 Oct;5(10):2512-21. (PMID: 17041095) Nat Biotechnol. 2012 Sep;30(9):842-8. (PMID: 22965061) Nature. 2003 Dec 18;426(6968):789-96. (PMID: 14685227) Bioinformatics. 2007 May 1;23(9):1164-7. (PMID: 17344241) Stat Appl Genet Mol Biol. 2013 Oct 1;12(5):637-52. (PMID: 23942354) Breast Cancer Res Treat. 2013 Oct;141(3):409-20. (PMID: 24096568) Nature. 2012 Apr 18;486(7403):346-52. (PMID: 22522925) Clin Cancer Res. 2016 Oct 15;22(20):5068-5078. (PMID: 27172895) |
| معلومات مُعتمدة: | 16942 United Kingdom CRUK_ Cancer Research UK; P30 CA016672 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Investigator: E Borgen; O Engebråten; Ø Fodstad; B Fritzman; Ø Garred; GA Geitvik; S Hofvind; HG Russnes; HK Skjerven; T Sørlie Keywords: Breast cancer; Consensus clustering; Integration; Luminal A; MicroRNA |
| المشرفين على المادة: | 0 (Biomarkers, Tumor) 0 (MicroRNAs) 0 (RNA, Messenger) |
| تواريخ الأحداث: | Date Created: 20170331 Date Completed: 20170807 Latest Revision: 20240525 |
| رمز التحديث: | 20240525 |
| مُعرف محوري في PubMed: | PMC5372339 |
| DOI: | 10.1186/s13058-017-0812-y |
| PMID: | 28356166 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1465-542X |
|---|---|
| DOI: | 10.1186/s13058-017-0812-y |